Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

KALV

KalVista Pharmaceuticals Inc

May 29 • 04:00PM ET

26.87

+0.10 0.37 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: PTCT BMRN MIRM RYTM KRYS KYMR NUVL AXSM INCY URGN

| Held by: VTI XBI IWM VXF IWO IBB VTWO SCHA IWC MNA

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-4.00	Insider Own	18.84%	Shs Outstand	51.24M	Perf Week	0.37%
Market Cap	1.43B	Forward P/E	44.05	EPS next Y	0.61	Insider Trans	-3.33%	Shs Float	43.18M	Perf Month	0.75%
Enterprise Value	1.43B	PEG	-	EPS next Q	-	Inst Own	110.73%	Short Float	27.91%	Perf Quarter	65.05%
Income	-203.10M	P/S	1000.41	EPS this Y	57.08%	Inst Trans	-2.17%	Short Ratio	3.62	Perf Half Y	102.33%
Sales	1.43M	P/B	-	EPS next Y	170.01%	ROA	-97.71%	Short Interest	12.05M	Perf YTD	66.38%
Book/sh	-0.38	P/C	5.02	EPS next 5Y	-	ROE	-190.18%	52W High	26.85 0.07%	Perf Year	125.99%
Cash/sh	5.35	P/FCF	-	EPS past 3/5Y	1.05% -5.91%	ROIC	-82.31%	52W Low	9.83 173.35%	Perf 3Y	183.44%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-9.33%	Volatility	0.19% 0.25%	Perf 5Y	-0.48%
Dividend TTM	-	EV/Sales	999.90	EPS Y/Y TTM	-13.14%	Oper. Margin	-14220.90%	ATR (14)	0.40	Perf 10Y	81.06%
Dividend Ex-Date	-	Quick Ratio	5.10	Sales Y/Y TTM	-	Profit Margin	-14242.57%	RSI (14)	74.73	Recom	2.71
Dividend Gr. 3/5Y	- -	Current Ratio	5.17	EPS Q/Q	59.00%	SMA20	0.44%	Beta	-0.12	Target Price	28.60
Payout	-	Debt/Eq	-	Sales Q/Q	-	SMA50	19.41%	Rel Volume	0.40	Prev Close	26.77
Employees	275	LT Debt/Eq	-	Earnings	Mar 25 BMO	SMA200	65.01%	Avg Volume	3.33M	Price	26.87
IPO	Apr 09, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	11.50% -100.00%	Trades		Volume	1,333,814	Change	0.37%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)